Neutralizing monoclonal antibody against ras oncogene product p21 which impairs guanine nucleotide exchange. 1987

S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih

The neutralizing monoclonal antibody Y13-259 severely hampers the nucleotide exchange reaction between p21-bound and exogenous guanine nucleotides but does not interfere with the association of GDP to p21. These results suggest that the nucleotide exchange reaction is critical for p21 function. Interestingly, the v-ras p21 has a much faster dissociation rate than the p21 of the c-ras proto-oncogene.

UI MeSH Term Description Entries
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D009856 Oncogene Proteins, Viral Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities. Viral Oncogene Proteins,Viral Transforming Proteins,v-onc Proteins,Transforming Proteins, Viral,v onc Proteins
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D006150 Guanine Nucleotides Guanine Nucleotide,Guanosine Phosphates,Nucleotide, Guanine,Nucleotides, Guanine,Phosphates, Guanosine
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000937 Antigen-Antibody Reactions The processes triggered by interactions of ANTIBODIES with their ANTIGENS. Antigen Antibody Reactions,Antigen-Antibody Reaction,Reaction, Antigen-Antibody,Reactions, Antigen-Antibody
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic

Related Publications

S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih
January 1995, Methods in enzymology,
S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih
September 1989, Nature,
S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih
August 2004, Biochemistry,
S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih
January 1991, Journal of molecular recognition : JMR,
S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih
November 1991, Nature,
S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih
June 2010, Hybridoma (2005),
S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih
October 2013, Frontiers in biology,
S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih
September 1987, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih
January 1989, Urologia internationalis,
S Hattori, and D J Clanton, and T Satoh, and S Nakamura, and Y Kaziro, and M Kawakita, and T Y Shih
December 1986, Journal of the National Cancer Institute,
Copied contents to your clipboard!